Published November 2019
| Version v1
Journal article
Net Pain Relief After Palliative Radiation Therapy for Painful Bone Metastases: A Useful Measure to Reflect Response Duration? A Further Analysis of the Dutch Bone Metastasis Study
Creators
- 1. Leeds Institute of Medical Research, University of Leeds, Leeds (United Kingdom)
- 2. Leeds Cancer Centre, Leeds NHS Teaching Hospitals Trust, Leeds, Leeds (United Kingdom)
- 3. Department of Radiation Oncology, Radboud University Medical Center, Nijmegen (Netherlands)
- 4. Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (United Kingdom)
- 5. Department of Radiotherapy, Leiden University Medical Centre, Leiden (Netherlands)
Description
Pain response rates are equivalent after single 8 Gy and fractionated palliative radiation therapy for bone metastases. Reirradiation remains more frequent after a single fraction, although this does not simply reflect pain recurrence. Given the possible role of stereotactic radiation therapy in providing durable pain control, measures of durability are required. Net pain relief (NPR), the proportion of remaining life spent with pain response, may provide this. This study assesses the use of NPR as an outcome measure after palliative radiation therapy for bone metastases.
Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2019.07.009;
- PII
- S0360301619334583;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 105
- Journal Issue
- 3
- Journal Page Range
- p. 559-566
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 55057319
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- HARDNESS; METASTASES; PAIN; RADIOTHERAPY; SERVICE LIFE; SKELETON; WEAR RESISTANCE
- Descriptors DEC
- BODY; LIFETIME; MECHANICAL PROPERTIES; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; SYMPTOMS; THERAPY
Optional Information
- Copyright
- Copyright (c) 2019 The Author(s). Published by Elsevier Inc.